Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Tumor”

9,265 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 9,265 results

Testing effectiveness (Phase 2)Ended earlyNCT03215030
What this trial is testing

Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Teva Branded Pharmaceutical Products R&D LLC 272
Early research (Phase 1)Looking for participantsNCT02998567
What this trial is testing

Combination Study of Guadecitabine/ASTX727 and Pembrolizumab

Who this might be right for
Non Small Cell Lung Cancer
Royal Marsden NHS Foundation Trust 60
Testing effectiveness (Phase 2)Ended earlyNCT04786600
What this trial is testing

A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 Trial

Who this might be right for
Metastatic Colorectal Cancer
University of Florida 6
Testing effectiveness (Phase 2)Study completedNCT00005028
What this trial is testing

Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Maryland, Baltimore 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT06552572
What this trial is testing

Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Samsung Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00453895
What this trial is testing

Sunitinib in Refractory Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
University of Wuerzburg 39
Early research (Phase 1)Looking for participantsNCT06922539
What this trial is testing

ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
SciTech Development, Inc. 44
Early research (Phase 1)Study completedNCT01757639
What this trial is testing

Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+3 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00064012
What this trial is testing

Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Wisconsin, Madison 4
Testing effectiveness (Phase 2)Study completedNCT00003281
What this trial is testing

Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 84
Early research (Phase 1)Study completedNCT03441555
What this trial is testing

Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 36
Testing effectiveness (Phase 2)Ended earlyNCT01109615
What this trial is testing

Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations

Who this might be right for
Metastatic Colorectal Cancer
Vejle Hospital 40
Early research (Phase 1)UnknownNCT04689308
What this trial is testing

This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies

Who this might be right for
Relapsed/Refractory B-cell Malignancies
Minghui Pharmaceutical (Shanghai) LTD 57
Not applicableEnded earlyNCT01954576
What this trial is testing

NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
GlioblastomaBrain Neoplasms
University of Florida 21
Early research (Phase 1)Study completedNCT01471210
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma
Bristol-Myers Squibb 124
Early research (Phase 1)Study completedNCT00095160
What this trial is testing

Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors

Who this might be right for
Neoplasms
Masonic Cancer Center, University of Minnesota 42
Testing effectiveness (Phase 2)Looking for participantsNCT06316960
What this trial is testing

Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation

Who this might be right for
AML, ChildhoodRelapse/RecurrenceRefractory AML+2 more
Children's Hospital of Soochow University 50
Testing effectiveness (Phase 2)WithdrawnNCT02115035
What this trial is testing

A Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib

Who this might be right for
Multiple Myeloma
University of Arkansas
Testing effectiveness (Phase 2)Study completedNCT03744676
What this trial is testing

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

Who this might be right for
Lymphoma, Non-HodgkinLymphomaLymphoma, B-Cell+7 more
Juno Therapeutics, a Subsidiary of Celgene 104
Early research (Phase 1)Study completedNCT00006340
What this trial is testing

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

Who this might be right for
LeukemiaLymphomaPrecancerous Condition+1 more
Boston Medical Center
Load More Results